ArticleClinical and molecular hepatology2026

Besifovir: a viable option for long-term disease control in chronic hepatitis B: Editorial on "Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial".

Wai-Kay SetoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.